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Introduction
The recent emergence of the novel coronavirus disease of 2019 (COVID-19) in Wuhan,
China and its rapid spread across the world has posed a global health emergency. Scientists and
researchers across the world are working together to improve the methods of detection and
generate a vaccine that will cure the disease. However, in order to develop therapeutic strategies
and techniques for the treatment of COVID-19, the structure of SARS-CoV-2 must be entirely
scrutinized and comprehended. This review illustrates the similarities and differences between
SARS-CoV-2 and other coronaviruses, while also indicating why the development of this lethal
viral RNA can only be a result of natural evolution.
1. Spike Protein Structure
Coronaviruses (CoVs) are large enveloped viruses with a positive single-stranded RNA
genome. They belong to the subfamily Coronavirinae within the family Coronaviridae, which is
part
of
the
Nidovirales
order,
and
can
be
classified
into
four
genera: Alphacoronavirus, Betacoronavirus, Gammacoronavirus, and Deltacoronavirus. Among
all CoVs identified so far, seven have the ability to infect humans, including human coronavirus
229E (HCoV-229E) and human coronavirus NL63 (HCoV-NL63), which belong to alpha-CoVs1, as
well as human coronavirus OC43 (HCoV-OC43), human coronavirus HKU1 (HCoV-HKU1), severe
acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome
coronavirus (MERS-CoV), and the newly emerged coronavirus (2019-nCoV), which are known to
be beta-CoVs and are the focus of this study (Figure 1)2.
Coronaviruses have the largest genome among all RNA viruses, typically ranging from 27
to 32 kb3. The genetic material of the virus is packed inside a helical capsid formed by the
nucleocapsid protein (N) and further enclosed by an envelope that contains: the membrane
protein (M) and the envelope protein (E), which are essential for cellular assembly, and the spike
protein (S), which mediates virus entry into the host cells and therefore is the viral protein of
interest of most scientific studies3. As explained in the literature, S is a viral fusion protein that
promotes host attachment and synthesis of the membranes during entry4. Due to these qualities,
S determines host range and cell tropism which differs significantly among coronaviruses and
serves as the main point for comparison among the viruses. The S protein has been intensely
scrutinized by scientists and researchers from all over the globe as it is the distinguishing feature
that can be used to characterize coronaviruses; therefore, it will be a point of focus.
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Figure 1. Classification of Coronaviruses. Representative coronaviruses in each genus are HCoV-229E and HCoVNL63 for the genus Alphacoronavirus. SARS-CoV, MERS-CoV, and SARS-CoV-2 for the genus Betacoronavirus. AIBV
for the genus Gammacoronavirus. PdCV for the genus Deltacoronavirus.

According to a study conducted in 2016, the coronavirus spike protein contains three
segments: an ectodomain with a receptor-binding subunit S1 and a membrane-fusion subunit S2,
a single-pass transmembrane anchor, and a short intracellular tail5. Electron microscopy
experiments done by this same study revealed that the spike is a clove-shaped trimer with three
S1 units and a trimeric S2 unit5. When entering the host cell, S1 of the virus binds to a receptor
on the host cell surface for viral attachment, and the S2 unit assists with fusion between the host
and viral membranes, allowing the viral genetic material to penetrate and enter host cells3.
However, this binding interaction differs among the multiple coronaviruses. According to a recent
study, the receptor-binding S protein of SARS-CoV-2 encoded by the S gene was highly divergent
from other CoVs, with less than 75% nucleotide sequence identity to all SARSr-CoVs, except for a
93.1% nucleotide identity to RaTG136. As portrayed in the results, the S genes of 2019-nCoV and
RaTG13 are longer than the other SARSr-CoVs. The three short insertions in the N-terminal
domain and differences in four out of the five key residues in the receptor binding motif (RBM)
region is what distinguishes the S gene of SARS-CoV-2 from the sequence of SARS-CoV and makes
the novel COVID-19 exceptional6.
2. Receptor Binding Domains and Receptor Binding Motifs
Although the receptor binding domains (RBDs) among the Betacoronaviruses are very
similar, their receptor binding motifs (RBMs) differ. This explains why coronaviruses identify
different receptors and attack their targeted cells uniquely. Similar to HCoV-NL632, SARS-CoV and
SARS-CoV-2 recognize the angiotensin-converting enzyme 2 (ACE2) as the receptor on the host
cell through the RBD (CTP) region of its S1 unit7, while MERS-CoV utilizes dipeptidyl peptidase 4
(DPP4) as a receptor through the RBD (CTD) region8. Not all coronaviruses attach to the host cells
through the same receptors; it has been identified that the ACE2 is the preferred binding
2

Seton Hall Biochemistry II Annals of Student Reviews
Vol 1. No. 1
2020

structure of SARS-CoV and SARS-CoV-2, which differs from the other mechanisms of viral
attachment and entry exhibited by other viruses.
The genome of SARS-CoV-2 encodes pp1a and pp1ab, and eight accessory proteins along
with the four main proteins previously discussed9 The MERS-CoV genome is about 30 kb in length
and encodes pp1a, pp1ab and five accessory proteins along with the four main proteins10. Recent
studies have found that SARS-CoV-2 virus is 79.5% identical to the sequence found in SARS-CoV6
as it encodes pp1ab, and six accessory proteins along with the four main proteins. The similarity
in structure and sequence supports the hypothesis that SARS-CoV-2 evolved from SARS-CoV RBDs
in an attempt to improve binding affinity to the same ACE2 receptor11; however, the two viruses
differ in their receptor binding motifs.
Structural studies have shown SARS-CoV-2 RBD has a unique Lys417 residue on its RBM
region that forms salt-bridge interactions with the Asp30 in the ACE2 of its target cells; on the
other hand, SARS-CoV lacks this amino acid and instead it has a valine residue that does not
participate in ACE2 binding11. This lysine residue gives a positive-charged region on the SARSCoV-2 RBD that is absent on the SARS-CoV RBD, an alteration that influences the binding affinity
difference of the SARS-CoV-2 and SARS-CoV to the ACE2 receptor11. Although these studies were
able to identify some residues that are potentially involved in the SARS-CoV-2-ACE2 interaction,
the actual interaction remains elusive because computer modelling of the RBD, particularly for
the RBM, appeared incomplete when a single spike protein was investigated 11. Even though
scientists have yet to crystallize the structure of the RBM in the SARS-CoV-2 RBD and the
interaction still remains elusive, these findings illustrating the sequence similarities and
discrepancies between SARS-CoV and SARS-CoV-2 will serve as a foundation for the development
of the crystal structure of this region.
Not only does the evolution of the receptor binding motif distinguishes SARS-CoV-2 from
any other coronavirus, but it also provides an account to counteract previous claims that the viral
RNA was genetically modified in a laboratory. Early papers regarding the origin of the virus
suggested that four insertions in the S protein of SARS-CoV-2 resembled amino acid residues in
key structural proteins of HIV, the virus that causes AIDS12. These premature theories led to the
speculation that 2019-nCoV had been genetically modified in the lab to use as a bioweapon,
causing controversy within the scientific community. Most researchers believe that the
experiments that suggest that the development of SARS-CoV-2 could not have been fortuitous in
nature were rushed and provided miscalculated results. To be able to claim that 2019-nCoV
derived from gene fragments of HIV-1, both viruses would need to co-infect the same cells.
However, the host cells for bat CoV and HIV-1 are different, and therefore it is high unlikely that
they exchange genetic material13.
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Conclusions
Despite the conspiracy theories circulating the origin of the virus, the scientific data
illustrated in this review shows that the development of SARS-CoV-2 was a result of natural
selection and not of purposeful manipulation. This review goes into detail regarding the
structural comparison between 2019-nCoV and other coronaviruses, the genetic make-up
discussed in here shows that SARS-CoV-2 has components that differ significantly from other
known viruses. These discrepancies reduce the possibility of a man-made virus because these
structures have not been identified in other viral RNAs, which demonstrates that SARS-CoV-2 is
not derived from any previous used virus backbone and therefore is a product of nature itself
and evolution. Nonetheless, further analysis of the viral structure needs to be accomplished to
develop a successful and efficient therapeutic treatment for COVID-19. All of the scientific papers
cited in this report offer valuable information regarding the similarities and differences between
SARS-CoV-2 and other coronaviruses and establish the foundation of the assembly of the virus
that may be used in future works to crystallize the final structure of the virus in its entirety.
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